Identification of immune cells in benign and malignant thymus tumors: a Mendelian randomization study
Using genetic methodologies, we identified a robust link between immune cells and both benign and malignant thymic tumors. This study highlights the distinct immune phenotypes between benign and malignant thymic tumors, shedding light on their immunological mechanisms and suggesting new avenues for clinical immunotherapy.
Authors
- Chuan Yao
- Liancheng Ruan (ORCID: https://orcid.org/0000-0002-5969-4428)
- Wei Xiong (ORCID: https://orcid.org/0000-0001-8870-8289)
- Deyuan Zhang (ORCID: https://orcid.org/0000-0002-4731-7211)
- Silin Wang
- Wenxiong Zhang (ORCID: https://orcid.org/0000-0003-2962-0847)
- Sheng Hu (ORCID: https://orcid.org/0000-0001-6046-3478)
- Nuo Yan
- Yang Zhang
- Yiping Wei (ORCID: https://orcid.org/0000-0002-7272-1339)
Institutions
- Jiujiang University (CN)
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Annals of Medicine and Surgery
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1097/ms9.0000000000004395
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00